PubMed:14707489 / 732-821
Annnotations
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T7","span":{"begin":0,"end":89},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":89},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Targeting glycyrrhetin to HSC might reduce its adverse affects and increase the efficacy."}
Anatomy-UBERON
{"project":"Anatomy-UBERON","denotations":[{"id":"T7","span":{"begin":26,"end":29},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CL_0000632"}],"text":"Targeting glycyrrhetin to HSC might reduce its adverse affects and increase the efficacy."}
CL-cell
{"project":"CL-cell","denotations":[{"id":"T6","span":{"begin":26,"end":29},"obj":"Cell"}],"attributes":[{"id":"A6","pred":"cl_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CL:0000632"}],"text":"Targeting glycyrrhetin to HSC might reduce its adverse affects and increase the efficacy."}